review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1018361202 |
P356 | DOI | 10.1023/A:1007093521681 |
P698 | PubMed publication ID | 10696508 |
P5875 | ResearchGate publication ID | 12618165 |
P50 | author | William M Pardridge | Q33489592 |
P2093 | author name string | Golden PL | |
P2860 | cites work | Biochemistry of multidrug resistance mediated by the multidrug transporter | Q29616476 |
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites | Q33832954 | ||
Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein | Q34040187 | ||
Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate | Q34058435 | ||
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs | Q34059522 | ||
MDR1 gene expression in brain of patients with medically intractable epilepsy | Q34059935 | ||
Quantitative assessment of blood-brain barrier damage during microdialysis | Q34379223 | ||
Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium | Q34402344 | ||
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants | Q34488592 | ||
P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells | Q34538994 | ||
Expression of a multidrug-resistance gene in human tumors and tissues | Q34586576 | ||
In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier | Q34725577 | ||
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump | Q35749376 | ||
Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein | Q35884806 | ||
Microvessels Isolated from Rat Brain: Localization of Astrocyte Processes by Immunohistochemical Techniques | Q36587677 | ||
A new mammalian DNA topoisomerase I poison Hoechst 33342: cytotoxicity and drug resistance in human cell cultures. | Q36770732 | ||
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs | Q37355653 | ||
Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations | Q40618716 | ||
Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro. | Q41175649 | ||
Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization | Q41206360 | ||
Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers | Q41245940 | ||
P-glycoprotein of blood brain barrier: cross-reactivity of Mab C219 with a 190 kDa protein in bovine and rat isolated brain capillaries | Q41379122 | ||
Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. | Q41912189 | ||
Functional involvement of P-glycoprotein in blood-brain barrier | Q41969434 | ||
Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies | Q42812351 | ||
Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein | Q42822886 | ||
Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability | Q43857798 | ||
Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response | Q45113193 | ||
P-glycoprotein expression in brain capillary endothelial cells after focal ischaemia in the rat. | Q48116094 | ||
Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats. | Q48143376 | ||
High levels of P-glycoprotein detected in isolated brain capillaries | Q48233025 | ||
Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells | Q48394828 | ||
Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier | Q48431164 | ||
Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo | Q48643049 | ||
Brain microvascular and astrocyte localization of P-glycoprotein | Q48793395 | ||
The multidrug-resistance gene MDR1 is expressed in human glial tumors | Q48819555 | ||
Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues | Q48913115 | ||
Specialized localization of P-glycoprotein recognized by MRK 16 monoclonal antibody in endothelial cells of the brain and the spinal cord | Q48930125 | ||
Mouse multidrug resistance 1a/3 gene is the earliest known endothelial cell differentiation marker during blood-brain barrier development. | Q52210355 | ||
Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. | Q54231039 | ||
Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody | Q54249527 | ||
Cellular localization of P-glycoprotein in brain versus gonadal capillaries | Q71175387 | ||
Interaction of drugs with P-glycoprotein in brain capillaries | Q71598892 | ||
Comparisons of P‐glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta | Q71816143 | ||
Microvessels Isolated from Brain: Localization of Muscarinic Sites by Radioligand Binding and Immunofluorescent Techniques | Q71825428 | ||
Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats | Q71840015 | ||
P433 | issue | 2 | |
P921 | main subject | multiple drug resistance | Q643839 |
microvessel | Q6840468 | ||
P304 | page(s) | 165-181 | |
P577 | publication date | 2000-04-01 | |
P1433 | published in | Cellular and Molecular Neurobiology | Q2333197 |
P1476 | title | Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain | |
P478 | volume | 20 |
Q98564393 | Advancing brain barriers RNA sequencing: guidelines from experimental design to publication |
Q33985133 | Blood-brain barrier active efflux transporters: ATP-binding cassette gene family |
Q38058372 | Blood-brain barrier, epileptogenesis, and treatment strategies in cortical dysplasia |
Q35126422 | Changing patterns in the neuropathogenesis of HIV during the HAART era. |
Q40324864 | Confocal microscopy studies of a model oligoribonucleotide HIV inhibitor |
Q33851314 | Determinants of passive drug entry into the central nervous system |
Q34530624 | Drug efflux transporters in the CNS. |
Q48413155 | Effect of hemorrhagic shock on apoptosis and energy-dependent efflux system in the brain |
Q48333182 | Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors |
Q48543194 | Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes |
Q46417699 | Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables |
Q28346485 | Ivermectin excretion by isolated functionally intact brain endothelial capillaries |
Q44136566 | Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions |
Q30320568 | Lipophilicities of baclofen ester prodrugs correlate with affinities to the ATP-dependent efflux pump P-glycoprotein: relevance for their permeation across the blood-brain barrier? |
Q33569245 | Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy |
Q44650856 | Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions |
Q35592472 | New concepts in bilirubin encephalopathy. |
Q48669608 | Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. |
Q34502169 | P-glycoprotein and bilirubin disposition |
Q38487199 | Placental buffering of maternal steroid hormone effects on fetal and yolk hormone levels: a comparative study of a viviparous lizard, Sceloporus jarrovi, and an oviparous lizard, Sceloporus graciosus |
Q36136731 | Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain. |
Q37391961 | Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents |
Q44671680 | Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET. |
Q48168333 | Relationship between expression of multiple drug resistance proteins and p53 tumor suppressor gene proteins in human brain astrocytes |
Q35029495 | Role of P-glycoprotein in pharmacokinetics: clinical implications |
Q42792283 | Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation |
Q43069428 | The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid. |
Q34558556 | The impact of efflux transporters in the brain on the development of drugs for CNS disorders |
Q33227764 | The rat blood-brain barrier transcriptome |
Search more.